Views & Analysis | Perspectives on pharma industry issues

Digital

Abstract AI concept, turquoise hexagonals on dark background

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

R&D

A certificate of analysis should be evidence, not a sales do...

Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.

R&D

From phase 1 to phase 3: Scaling radiopharmaceutical trials

Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.

Patients

pharmaphorum podcast Episode 285, Donna Cryer, CryerHealth, LLC

Patients not just at the table, but creating their own: In c...

Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.

R&D

Gravity is an experimental variable pharma has rarely been a...

Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.

Articles

Are you ready for the new EU pharmacovigilance legislation c...

Graeme Ladds shares his thoughts on the new EU pharmacovigilance legislation for July 2012, specifically looking at expedited reporting, literature searching and the Periodic Safety Update Reports. There have been progressive changes in legislation since the emergence of Vol IXa in January 2007...

Articles

Physician perspectives: Dr Andrew Doan

We speak with Dr Andrew Doan about his experiences using social media, looking at how pharma can overcome the challenges it faces online, how practices can turn negative reviews into a positive and how he sees the future of healthcare. Continuing our ‘Physician perspective’ series, we speak to Dr Andrew Doan, who is not only a comprehensive ophthalmologist...

Articles

Mobile technology: pharma companies struggle to engage with ...

Dr Tim Ringrose explores how pharma can better engage with physicians via mobile technology. Thanks to the high uptake of smartphones and tablet devices by hospital doctors and GPs, the medical profession now has unprecedented...

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.